Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Castle Bioscience Sees FY24 Revenue $235M-$240M Vs $214.693M

Author: Benzinga Newsdesk | February 28, 2024 06:14pm

Posted In: CSTL